Patents by Inventor Anna N. Yaroslavsky

Anna N. Yaroslavsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11944450
    Abstract: Many treatments of skin cancer need an accurate assessment of the margins of the tumor. Spectrally-encoded optical polarization imaging improves upon the demarcation of skin cancer such as keratinocytic carcinomas. When the clinician can outline the clinical boundary of each lesion, surgery and other treatments can be more efficient and effective. Optical images of the lesions are acquired at various wavelengths, then spectrally-encoded. Spectral-encoding of the images minimizes the impact of background pigmentation and vascularization so that the tumor can be accurately visualized.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: April 2, 2024
    Assignee: UNIVERSITY OF MASSACHUSETTS
    Inventor: Anna N. Yaroslavsky
  • Patent number: 11627908
    Abstract: Instruments and methods for wide-field polarized imaging of the skin to determine an outer lesion margin objectively in vivo to provide guidance to a surgeon. Quantitative characterization of collagen structures in the skin can be used to determine the outer lesion margin or monitor skin treatment.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: April 18, 2023
    Assignee: UNIVERSITY OF MASSACHUSETTS
    Inventors: Anna N. Yaroslavsky, Victor Neel
  • Publication number: 20220104707
    Abstract: Currently most cancers, including breast cancers, are removed without any intraoperative margin control. Post-operative methods inspect 1-2% of the surgical margin and are prone to sampling errors. The present invention relates to an optical imaging system that will enable evaluation of the surgical margin in vivo and in real-time. The invention provides for simultaneous fluorescence and fluorescence polarization imaging. The contrast of the acquired images will be enhanced using fluorescent agents approved for diagnostic use in patients. As the staining pattern of fluorescence images is similar to that of histology, and the values of fluorescence polarization are significantly higher in cancerous as compared to normal cells, the invention provides for further improvements in diagnostic methods. The systems and methods can be applied to the intra-operative delineation of cancerous tissue.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventors: Anna N. Yaroslavsky, Rakesh Patel, Dennis Wirth
  • Patent number: 11219370
    Abstract: Currently most cancers, including breast cancers, are removed without any intraoperative margin control. Post-operative methods inspect 1-2% of the surgical margin and are prone to sampling errors. The present invention relates to an optical imaging system that will enable evaluation of the surgical margin in vivo and in real-time. The invention provides for simultaneous fluorescence and fluorescence polarization imaging. The contrast of the acquired images will be enhanced using fluorescent agents approved for diagnostic use in patients. As the staining pattern of fluorescence images is similar to that of histology, and the values of fluorescence polarization are significantly higher in cancerous as compared to normal cells, the invention provides for further improvements in diagnostic methods. The systems and methods can be applied to the intra-operative delineation of cancerous tissue.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: January 11, 2022
    Assignee: THE UNIVERSITY OF MASSACHUSETTS
    Inventors: Anna N. Yaroslavsky, Rakesh Patel, Dennis Wirth
  • Publication number: 20210251564
    Abstract: Many treatments of skin cancer need an accurate assessment of the margins of the tumor. Spectrally-encoded optical polarization imaging improves upon the demarcation of skin cancer such as keratinocytic carcinomas. When the clinician can outline the clinical boundary of each lesion, surgery and other treatments can be more efficient and effective. Optical images of the lesions are acquired at various wavelengths, then spectrally-encoded. Spectral-encoding of the images minimizes the impact of background pigmentation and vascularization so that the tumor can be accurately visualized.
    Type: Application
    Filed: September 12, 2019
    Publication date: August 19, 2021
    Inventor: Anna N. Yaroslavsky
  • Patent number: 10945656
    Abstract: The present invention relates to systems and methods or wide-field polarized imaging of the skin. Preferred embodiments of the invention provide quantitative characterization of collagen structures in the skin and can be used to monitor skin treatment. A preferred embodiment can comprise a handheld imaging device that generates polarized images at different depths beneath a dermal surface and a data processor to process image data.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: March 16, 2021
    Assignee: THE UNIVERSITY OF MASSACHUSETTS
    Inventors: Anna N. Yaroslavsky, Xin Feng
  • Publication number: 20210052212
    Abstract: Instruments and methods for wide-field polarized imaging of the skin to determine an outer lesion margin objectively in vivo to provide guidance to a surgeon. Quantitative characterization of collagen structures in the skin can be used to determine the outer lesion margin or monitor skin treatment.
    Type: Application
    Filed: March 18, 2018
    Publication date: February 25, 2021
    Inventors: Anna N. Yaroslavsky, Victor Neel
  • Publication number: 20180206727
    Abstract: Currently most cancers, including breast cancers, are removed without any intraoperative margin control. Post-operative methods inspect 1-2% of the surgical margin and are prone to sampling errors. The present invention relates to an optical imaging system that will enable evaluation of the surgical margin in vivo and in real-time. The invention provides for simultaneous fluorescence and fluorescence polarization imaging. The contrast of the acquired images will be enhanced using fluorescent agents approved for diagnostic use in patients. As the staining pattern of fluorescence images is similar to that of histology, and the values of fluorescence polarization are significantly higher in cancerous as compared to normal cells, the invention provides for further improvements in diagnostic methods. The systems and methods can be applied to the intra-operative delineation of cancerous tissue.
    Type: Application
    Filed: December 11, 2017
    Publication date: July 26, 2018
    Applicant: The University of Massachusetts
    Inventors: Anna N. Yaroslavsky, Rakesh Patel, Dennis Wirth
  • Publication number: 20160066833
    Abstract: The present invention relates to systems and methods or wide-field polarized imaging of the skin. Preferred embodiments of the invention provide quantitative characterization of collagen structures in the skin and can be used to monitor skin treatment. A preferred embodiment can comprise a handheld imaging device that generates polarized images at different depths beneath a dermal surface and a data processor to process image data.
    Type: Application
    Filed: April 4, 2014
    Publication date: March 10, 2016
    Inventors: Anna N. Yaroslavsky, Xin Feng
  • Publication number: 20150164327
    Abstract: The present invention relates to the use of optical and terahertz imaging of tissue for measuring characteristics to assist in diagnosis. A light delivery and collection system is used that can aid in the detection of tumor margins, for example. A data processor processes the image data to determine characteristics of a region of tissue.
    Type: Application
    Filed: July 15, 2013
    Publication date: June 18, 2015
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventors: Anna N. Yaroslavsky, Robert H. Giles, Cecil S. Joseph, Rakesh Patel
  • Publication number: 20130324846
    Abstract: Currently most cancers, including breast cancers, are removed without any intraoperative margin control. Post-operative methods inspect 1-2% of the surgical margin and are prone to sampling errors. The present invention relates to an optical imaging system that will enable evaluation of the surgical margin in vivo and in real-time. The invention provides for simultaneous fluorescence and fluorescence polarization imaging. The contrast of the acquired images will be enhanced using fluorescent agents approved for diagnostic use in patients. As the staining pattern of fluorescence images is similar to that of histology, and the values of fluorescence polarization are significantly higher in cancerous as compared to normal cells, the invention provides for further improvements in diagnostic methods. The systems and methods can be applied to the intra-operative delineation of cancerous tissue.
    Type: Application
    Filed: February 17, 2012
    Publication date: December 5, 2013
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventors: Anna N. Yaroslavsky, Rakesh Patel, Dennis Wirth
  • Publication number: 20120170037
    Abstract: The present invention is directed to a novel multi-spectral exogenous fluorescence polarization imaging technique that enables rapid imaging of large tissue fields. The imaging device includes a tunable monochromatic light source and a CCD camera. Linear polarizers are placed into both the incident and collected light pathways in order to obtain fluorescence polarization or/and anisotropy image. To acquire exogenous fluorescence image, fluorescent contrast agents are delivered to a target tissue.
    Type: Application
    Filed: January 13, 2012
    Publication date: July 5, 2012
    Applicant: The General Hospital Corporation
    Inventors: Anna N. Yaroslavsky, Richard R. Anderson
  • Publication number: 20120071764
    Abstract: A device for wide-field and high resolution imaging of an object surface includes first and second imaging modalities, a lens associated with the second imaging modality. The first imaging modality is high resolution with a first observation line. The second imaging modality is arranged in an image plane at a first angle with respect to an object plane and has a second observation line and a wider imaging field than the first imaging modality. The lens associated with the second imaging modality is arranged in a lens plane at a second angle with respect to the object plane, where the second angle being equal to about one-half of the first angle. The first and second imaging modalities are mutually arranged such that the first and second optical axes intersect at a point on the object plane.
    Type: Application
    Filed: September 14, 2011
    Publication date: March 22, 2012
    Applicant: The General Hospital Corporation
    Inventors: Anna N. Yaroslavsky, Robert H. Webb, Richard R. Anderson
  • Patent number: 8139211
    Abstract: The present invention is directed to a novel multi-spectral exogenous fluorescence polarization imaging technique that enables rapid imaging of large tissue fields. The imaging device includes a tunable monochromatic light source and a CCD camera. Linear polarizers are placed into both the incident and collected light pathways in order to obtain fluorescence polarization or/and anisotropy image. To acquire exogenous fluorescence image, fluorescent contrast agents are delivered to a target tissue.
    Type: Grant
    Filed: July 21, 2009
    Date of Patent: March 20, 2012
    Assignee: The General Hospital Corporation
    Inventors: Anna N. Yaroslavsky, Richard Rox Anderson
  • Publication number: 20120029348
    Abstract: The present invention is directed to a novel multi-wavelength imaging method and apparatus that enables rapid imaging of tissue regions with accurate identification of tissue types within the region. Optical properties, such as co-polarized or cross-polarized fluorescence or reflectance intensity, optical density and/or reflectance, can be determined at a plurality of locations within the tissue region for each wavelength. Said properties at the two wavelengths, including calculated derivatives of the optical property with respect to wavelength, can be analyzed to image tissue structures and identify tissue types within the tissue region more accurately than can be achieved based on properties measured at a single wavelength.
    Type: Application
    Filed: April 13, 2010
    Publication date: February 2, 2012
    Applicant: The Gemeral Hospital Corporation
    Inventors: Anna N. Yaroslavsky, Elena Salomatina, Richard R. Anderson
  • Publication number: 20100053607
    Abstract: The present invention is directed to a novel multi-spectral exogenous fluorescence polarization imaging technique that enables rapid imaging of large tissue fields. The imaging device includes a tunable monochromatic light source and a CCD camera. Linear polarizers are placed into both the incident and collected light pathways in order to obtain fluorescence polarization or/and anisotropy image. To acquire exogenous fluorescence image, fluorescent contrast agents are delivered to a target tissue.
    Type: Application
    Filed: July 21, 2009
    Publication date: March 4, 2010
    Applicant: The General Hospital Corporation
    Inventors: Anna N. Yaroslavsky, Richard R. Anderson
  • Patent number: 7627363
    Abstract: The present invention is directed to a novel multi-spectral contrast agent-enhanced polarized light imaging technique that enables rapid imaging of large tissue fields. The imaging device includes a tunable monochromatic light source and a CCD camera. Linear polarizers are placed into both the incident and collected light pathways in order to limit the measurement volume to the superficial tissue layers. To enhance the tumor contrast in the image, aqueous solutions of toluidine blue or methylene blue are topically applied.
    Type: Grant
    Filed: March 18, 2004
    Date of Patent: December 1, 2009
    Assignee: The General Hospital Corporation
    Inventors: Anna N. Yaroslavsky, R. Rox Anderson
  • Patent number: 7564550
    Abstract: The present invention is directed to a novel multi-spectral exogenous fluorescence polarization imaging technique that enables rapid imaging of large tissue fields. The imaging device includes a tunable monochromatic light source and a CCD camera. Linear polarizers are placed into both the incident and collected light pathways in order to obtain fluorescence polarization or/and anisotropy image. To acquire exogenous fluorescence image, fluorescent contrast agents are delivered to a target tissue.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: July 21, 2009
    Assignee: The General Hospital Corporation
    Inventors: Anna N. Yaroslavsky, Richard Rox Anderson
  • Publication number: 20090076396
    Abstract: An apparatus for imaging cancer in which cancer tissue is contrasted against adjacent healthy tissue. The apparatus includes illumination and, possibly polarization means configured to provide illumination light on a region of tissue. Detection means are optically coupled to the illumination means, the detection means being adapted to detect reflected light from the tissue (and its polarization state, if applicable) when the tissue is illuminated by the illumination means. Filtering means are optically coupled to the detection means. The filtering means are configured to filter the illumination light and/or reflected light to pass only light within a range, or any subrange between about 1050 to about 1400 nm. Methods for imaging cancer contrast cancer tissue against adjacent healthy tissue.
    Type: Application
    Filed: September 16, 2008
    Publication date: March 19, 2009
    Applicant: The General Hospital Corporation
    Inventors: Anna N. Yaroslavsky, Elena Salomatina
  • Patent number: 7289205
    Abstract: The present invention is directed to a novel multi-spectral exogenous fluorescence polarization imaging technique that enables rapid imaging of large tissue fields. The imaging device includes a tunable monochromatic light source and a CCD camera. Linear polarizers are placed into both the incident and collected light pathways in order to obtain fluorescence polarization or/and anisotropy image. To acquire exogenous fluorescence image, fluorescent contrast agents are delivered to a target tissue.
    Type: Grant
    Filed: September 20, 2004
    Date of Patent: October 30, 2007
    Assignee: The General Hospital Corporation
    Inventors: Anna N. Yaroslavsky, Richard R. Anderson